fig1

From: Short-term L-arabinose administration alleviates MASLD by remodeling gut microbiota and activating hepatic ATF5-dependent mitochondrial unfolded protein response

Short-term L-arabinose administration alleviates MASLD by remodeling gut microbiota and activating hepatic ATF5-dependent mitochondrial unfolded protein response

Figure 1. Short-term oral administration of L-arabinose can reduce body weight in mice. (A) construction process of L-arabinose gavage mouse model; (B) photos taken during mice sacrifice; (C) body weight during oral administration of arabinose in mice; (D) mouse blood glucose at week 12; (E) cholesterol content in mouse liver (μmol/mg protein); (F) Triglyceride content in mouse liver (μmol/mg protein). “*”Significant difference between the model group and gavage group. (****P < 0.0001, ***P < 0.001, **P < 0.01, and *P < 0.05). NCD: Normal chow diet; HFD: high-fat diet; LA: L-arabinose; TC: total cholesterol; TG: triglyceride.

fig1

Committee on Publication Ethics

Portico

Committee on Publication Ethics

Portico